Latest News

 Filter by Provider

REGENXBIO (NASDAQ:RGNX) is approaching pivotal trial results for its eye disease gene therapy and preparing a U.S. application for its Duchenne muscular dystrophy treatment, executives said during the company’s third-quarter earnings call. The company and partner AbbVie expect top-line results this

U.S. Bancorp (NYSE:USB) expects to restart share repurchases promptly after pausing them in the previous quarter, as it works to build capital and expand its capital markets business following the acquisition of BTIG, executives said at a conference. Chief Financial Officer John Stern said the bank

Beauty Health (NASDAQ:SKIN), referred to as SkinHealth Systems on its earnings call, reported a narrower revenue decline and higher adjusted earnings for the third quarter of 2026, as growth in consumables helped offset weaker equipment sales. Revenue fell 2.1% from a year earlier to $69.2 million,

Skyward Specialty Insurance Group (NASDAQ:SKWD) reported higher operating earnings and premium growth for the third quarter of 2026, even as executives described increasing competition in parts of the property and casualty insurance markets. Operating income rose to $58 million, or $1.28 per dilute

Informa TechTarget (NASDAQ:TTGT) lowered its full-year 2026 outlook after reporting a decline in third-quarter revenue, as customers took longer to commit to spending and a healthy sales pipeline converted more slowly than management expected. The company now expects full-year revenue to be modestl

Regency Centers (NASDAQ:REG) raised its full-year outlook after reporting stronger third-quarter property income and record leasing levels, while executives said growth in 2027 could moderate as occupancy gains slow and debt refinancing adds pressure to earnings. Same-property net operating income,

Assured Guaranty (NYSE:AGO) expects financial guaranty production to exceed $400 million in 2026, after growth across its business lines helped lift production 44% in the first nine months of the year. The company reported third-quarter adjusted operating income of $86 million, or $1.94 per share,

WillScot (NASDAQ:WSC) reported higher third-quarter revenue and raised its 2026 sales outlook as demand for modular space helped reverse a decline in units on rent. The company also offered an initial forecast for organic growth in 2027, while cautioning that the pace of future data center construct

Nutex Health (NASDAQ:NUTX) reported lower third-quarter revenue and earnings despite a rise in hospital visits, as executives pointed to prior-year revenue adjustments tied to collections under the federal independent dispute resolution process. Revenue fell to $217.6 million in the third quarter o

E.W. Scripps (NASDAQ:SSP) reported a third-quarter profit as record midterm political advertising boosted its local television business, and executives said they plan to use election-related cash to reduce debt. The company recorded $284 million in full-year Local Media political advertising revenu

Carlyle Secured Lending (NASDAQ:CGBD) reported third-quarter 2026 net investment income of $0.36 per share, covering its $0.35 base dividend, as higher income from joint ventures helped offset a smaller average loan portfolio. Net asset value rose to $15.65 per share as of Sept. 30 from $15.61 at t

Record awards and a $34.3 billion backlog meet a new round of cost pressure.

Moderna stock surged to a five-year high Friday on the back of its Street-walloping vaccine sales and guidance hike for the year.

Conversions slowed, but AI tools are pulling sellers deeper into the platform.

Political ad windfall masked softness in core advertising and networks.

Focal One sales grew, but deal timing pushed some placements into Q4.

Margins slipped on supply strain, but Plato and GRIN milestones stayed on track.

There's a missing piece of the puzzle that can't be overlooked.

NuScale Power signed an agreement to secure key nuclear reactor components. Could a major deal be on the horizon?

Customer inventory cuts hit Vafseo sales as a reimbursement cliff nears.

Restructuring reshapes the company around its experiences business.

Thursday was the Nasdaq's worst day since April 2025. Here's what history says often comes next and how to make a rough market work for you.

Management sees little acquisition value as oil drilling takes priority over gas.

Member tenure rose sharply as a CEO handoff approaches for 2027.

Title insurance company Fidelity National Financial (NYSE:FNF) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 11.2% year on year to...

New York growth is expected to continue despite rising competition.

Record sites and recurring demand lifted revenue, but margins slipped.

Gran Tierra's $1.33 billion asset sale could leave it debt-free.

Funding now covers operations, but NXT-41x clearance timing is still only a projection.

Europe softness weighed on sales, yet margins and billings kept growing.

Gross margin climbed, but management flagged rising Q4 spending ahead.

Altria remains an appealing investment in this turbulent market.

Product mix shifted lower as adjusted EBITDA turned positive this quarter.

Fiber gains accelerate while legacy declines weigh on updated guidance.

Data and transport drove 10% FFO growth before a planned restructuring.

Higher shipments and cost pressures shape the 2027 outlook.

Fiber gains surged while legacy declines forced a guidance cut.

Shopify stock fell after the company's revenue and GMV results fell short of analyst expectations.

Oil and gas company Granite Ridge Resources (NYSE:GRNT) reported Q3 2026 results topping the market’s revenue expectations, with sales up 57.3% year on year ...

Firefly just agreed to sell AST SpaceMobile $1.3 billion worth of rocket engines.

Debt-free balance sheet and rising occupancy shape its expansion plans.

Asia strength and automation demand carried quarterly results, while Europe stays uncertain.

Management sees its $40 billion volume goal arriving two years early

Predictions spending climbs as management maps a path back to profit.

Zero-margin device conversions weighed on margins this quarter, management says.

International shipments kept third-quarter revenue steady despite softer domestic NERLYNX sales.